Lawrence Rice MD

PubMed

• Long-term outcomes of light chain amyloidosis patients receiving heart transplant: A single-center experience.
  Khush Patel, Zoe H Tu, Carrie Yuen, Siddhartha Ganguly, Allison N Yun
  JHLT Open. 2025-08-01
• Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis.
  Akash Mukherjee, Cesar Gentille, Asmita Patel, Joe Ensor, Lawrence Rice
  International Journal of Hematology. 2024-09-01
• Interpreting coagulation mixing study results in the era of direct oral anticoagulants.
  Moon Joo Kim, Eric Salazar, Bonnie Philips, Lawrence Rice, Brian Castillo
  Blood Coagulation & Fibrinolysis. 2024-01-01

Journal Articles

• Heparin PF4 antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit  
  Wanat M, Fitousis K, Hall J, Rice L, Clin Appl Thrombos & Thrombolys, 1/1/2013
• Treatment of heparin-induced thrombocytopenia with direct thrombin inhibitors: trials results and implications  
  Jung M, Rice L, Clin Invest, 1/1/2013
• Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis  
  Kamble RT, Carrum G, Rice L, McCarthy J, Baker KR, Ramos CA, Adrogue H, Estep JD, Biol Blood Marrow Transpl, 1/1/2012

Books/Book Chapters

• Clinical Decision Support: Hematology. 
  Chapter: Heparin-Induced Thrombocytopenia. 
  Rice LEditors: Benz E, Berliner N, Brodsky R, Moake J.Decision Support in Medicine, Wilmington DE2013
• Protocolos en Cuidados Criticos 
  Chapter: Heparin-induced thrombocytopenia in the ICU. 
  Rice L, Baker KREditors: Rodriguez-Villar S.Marban Libros SL, Madrid, SpainEdition 2nd,2013
• Hematology: Basic Principles and Practice 
  Chapter: Neutrophilia, Neutropenia, Monocytosis and Monocytopenia. 
  Rice L, Jung MEditors: Hoffman R, et al.Elsevier, Philadelphia, PAEdition 6th,2012

Abstracts/Posters

• Changes in platelet count after Heart Mate II insertion: implications for rational use of anti-platelet factor IV antibodies.
  Alvarez P, Kassi M, Cordero-Reyes AM, Uribe C, De Hoyos P, Bhimaraj A, Trachtenberg BH, Ashrith G, Torre-Amione G, Rice L, Estep JD, J Heart Lung Transpl, 1/1/2014
• Acquired and hereditary hypercoagulable states in patients with continuous flow left ventricular assist devices: prevalence and thrombotic complications.
  Alvarez P, Cordero-Reyes AM, Kassi M, Uribe C, DeHoyos P, Bhimaraj A, Trachtenberg BH, Ashrith G, Rice L, Torre-Amione G, Estep JD, J Cardiac Fail, 1/1/2014
• Neighborhood Death Rate: A Big-Data Based Health Informatics Pipeline Helps Identify Factors Impacting Clinical Outcomes and Cost Effectiveness in Acute Myeloid Leukem...
  Yin Z, Konde AS, Puppala M, Srivastava P, Wong S, Rice L, Iyer SP, Blood, 1/1/2014

Lectures

• Immunosuppressive therapy of Aplastic anemia. 
  1/21/2015
• Immune Thrombocytopenia 
  Houston, TX - 1/18/2014
• Thrombocytopenic Disorders 
  Omni Hotel, Houston, TX - 1/4/2014

Other

• Management of HIT: Case-Based Studies. National Webinar 
  Rice L
  https://francefoundation.webex.com/francefoundation/
  1/1/2009
• Heparin-induced thrombocytopenia: accurate diagnosis and timely management. (Clinical curriculum enduring primer/CME). 
  Bauer KA, Levy JH, Rice L, The France Foundation
  http://www.HITeducation.com
  1/1/2008
• Raising awareness on HIT. CME Interactive case study. 
  Rice L
  http://www.HITeducation.com
  1/1/2008